Sign in

Jim Kammert

Managing Director and Senior Equity Analyst at Evercore

Jim Kammert is a Managing Director and Senior Equity Analyst at Evercore ISI, specializing in real estate sector research with an emphasis on REITs in retail and healthcare. He covers companies including Agree Realty, NNN REIT, and Healthpeak Properties, maintaining a success rate of approximately 73.8% with a mixed average return track record on platforms like TipRanks and StockAnalysis. Kammert began his current role at Evercore Group LLC in 2023 after previous experience at EII Capital Management, and is based in Chicago. He holds senior research credentials and is likely FINRA registered given his role, earning recognition for his targeted expertise in real estate equity research.

Jim Kammert's questions to W. P. Carey (WPC) leadership

Question · Q3 2025

Jim Kammert asked for visibility into the 2026 and 2027 lease expirations, specifically what percentage is actively being discussed with tenants versus those left until the last moment. He also inquired about any organic tilting towards industrial or retail across those two years.

Answer

Head of Asset Management Brooks Gordon confirmed that virtually all 2026 and 2027 expiring ABR is actively being worked on, as the company engages with tenants three to five years out. He noted that both years have a similar property type breakdown, with approximately 60% warehouse and industrial. Mr. Gordon highlighted opportunities in 2026 to re-lease high-quality warehouses in the Lehigh Valley at significantly higher rents, while other leases may have renewal options at continuing rents.

Ask follow-up questions

Fintool

Fintool can predict W. P. Carey logo WPC's earnings beat/miss a week before the call

Jim Kammert's questions to WELLTOWER (WELL) leadership

Question · Q3 2025

Jim Kammert asked for clarification on the accounting mechanics and calculation of the $1.1 billion non-cash charge related to the new compensation plan.

Answer

Co-President and CFO Tim McHugh explained that the $1.1 billion charge is an upfront expense piece of the plan, as detailed in the 10-Q, with an additional $200 million to be amortized over the subsequent 10 years of the plan.

Ask follow-up questions

Fintool

Fintool can predict WELLTOWER logo WELL's earnings beat/miss a week before the call

Let Fintool AI Agent track Jim Kammert for you

Get briefed when they ask questions on calls

Best AI Agent for Equity Research

Performance on expert-authored financial analysis tasks

Fintool-v490%
Claude Sonnet 4.555.3%
o348.3%
GPT 546.9%
Grok 440.3%
Qwen 3 Max32.7%

Try Fintool for free